To compare the efficacy of subthreshold diode laser photocoagulation with conventional threshold diode laser in clinically significant macular oedema (CSME) in diabetics. Prospective randomised ...

Please provide your email address to receive an email when new articles are posted on . A novel telemedicine approach combining the high speed of 5G wireless networks and navigated retinal laser ...

SAN FRANCISCO — Retinopathy of prematurity seems to respond equally to either an injection with aflibercept or laser photocoagulation when infants who were treated reached age 2 years, according to ...

There is no increased risk of tractional retinal detachment (TRD) associated with anti-VEGF (vascular endothelial growth factor) intravitreal injection only, compared with laser-only therapy, nor with ...

Diabetic eye disease is a leading cause of vision loss in individuals aged 20 to 74,(3) and diabetic macular edema (DME), left untreated, is the leading cause of blindness in diabetic patients. The ...

According to the authors, the risk of injury is higher for short-wave light (green laser pointers: wavelength 490-575 nanometers) than for long-wave light (red laser pointers: wavelength 635-750 ...

The Pew Charitable Trusts has named Alexander Sher, assistant professor of physics at UC Santa Cruz, a Pew Scholar in the Biomedical Sciences. Sher will receive a $240,000 award over four years to ...

Please provide your email address to receive an email when new articles are posted on . Retinopathy of prematurity, a neovascular retinal disorder of childhood, is a leading cause of visual morbidity ...

No, diabetes-related retinopathy is not reversible. But you can slow down progression or stop it from getting worse through diabetes management, eye injections, laser treatment, and more. Diabetic ...

Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

SAN ANTONIO -- Visual acuity in patients with diabetic macular edema (DME) improved significantly after an early switch to a dexamethasone implant following inadequate response to anti-VEGF therapy, a ...